135 related articles for article (PubMed ID: 25539371)
21. Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma.
Brodin NP; Maraldo MV; Aznar MC; Vogelius IR; Petersen PM; Bentzen SM; Specht L
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):433-45. PubMed ID: 24321783
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
Wong E; D'Souza DP; Chen JZ; Lock M; Rodrigues G; Coad T; Trenka K; Mulligan M; Bauman GS
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):830-41. PubMed ID: 15708263
[TBL] [Abstract][Full Text] [Related]
23. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
Aznar MC; Girinsky T; Berthelsen AK; Aleman B; Beijert M; Hutchings M; Lievens Y; Meijnders P; Meidahl Petersen P; Schut D; Maraldo MV; van der Maazen R; Specht L
Acta Oncol; 2017 Apr; 56(4):608-613. PubMed ID: 28105886
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
25. Role of radiation therapy for the treatment of lymph nodes in urologic malignancies.
Pugh TJ; Lee AK
Urol Clin North Am; 2011 Nov; 38(4):497-506, vii. PubMed ID: 22045180
[TBL] [Abstract][Full Text] [Related]
26. [Intensity modulated radiotherapy for intrathoracic cancers: a dangerous liaison? Our experience in the treatment of Hodgkin lymphoma mediastinal masses].
Girinsky T; Ghalibafian M; Paumier A
Cancer Radiother; 2011 Oct; 15(6-7):546-8. PubMed ID: 21885321
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients.
Andolino DL; Hoene T; Xiao L; Buchsbaum J; Chang AL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e667-71. PubMed ID: 21459527
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric comparison of doses to organs at risk using 3-D conformal radiotherapy versus intensity modulated radiotherapy in postoperative radiotherapy of periampullary cancers: implications for radiation dose escalation.
Bahl A; Kapoor R; Tomar P; Singh OA; Gupta R; Sharma SC
JOP; 2013 Jan; 14(1):39-43. PubMed ID: 23306333
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
30. Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks.
Kelsey CR; Beaven AW; Diehl LF; Prosnitz LR
Oncology (Williston Park); 2012 Dec; 26(12):1182-9, 1193. PubMed ID: 23413599
[TBL] [Abstract][Full Text] [Related]
31. Importance of PET/CT scan use in planning radiation therapy for lymphoma.
Milana MA; Marko E; Miroslav L; Tihomir D
Asian Pac J Cancer Prev; 2015; 16(5):2051-4. PubMed ID: 25773849
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
33. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
34. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer.
Selvaraj RN; Beriwal S; Pourarian RJ; Lalonde RJ; Chen A; Mehta K; Brunner G; Wagner KA; Yue NJ; Huq SM; Heron DE
Med Dosim; 2007; 32(4):299-304. PubMed ID: 17980832
[TBL] [Abstract][Full Text] [Related]
35. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
Holtzman A; Flampouri S; Li Z; Mendenhall NP; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):592-4. PubMed ID: 23477362
[No Abstract] [Full Text] [Related]
36. Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities.
Lv Y; Wang F; Yang L; Sun G
Cancer Radiother; 2014 Dec; 18(8):745-52. PubMed ID: 25451672
[TBL] [Abstract][Full Text] [Related]
37. An easy irradiation technique (partial half-beam) to reduce renal dose in radiotherapy of cervical cancer including paraaortic lymph nodes.
Vorwerk H; Wagner D; Christiansen H; Hess CF; Hermann RM
Strahlenther Onkol; 2008 Sep; 184(9):473-7. PubMed ID: 19016026
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
Zhang F; Zheng M
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
[TBL] [Abstract][Full Text] [Related]
39. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
[TBL] [Abstract][Full Text] [Related]
40. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
